Pendrell Corporation acquired 68.75% stake in Provitro Biosciences LLC for $16.6 million.
Pendrell Corporation (NasdaqGS:PCO) completed the acquisition of 68.75% stake in Provitro Biosciences LLC on February 21, 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
150,000 USD | -.--% |
|
-.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 139M | |
-5.88% | 419M | |
-2.93% | 316M | |
+89.47% | 170M | |
-16.03% | 138M | |
+14.76% | 86.61M | |
+102.08% | 80.33M | |
+81.19% | 60.33M |